The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1539
January 29, 2018
View Complete Issue         Table of Contents 2019 
Issue 1539
Subscribers: Log in to read full issue.  Not a subscriber?  Subscribe or purchase issue.
A Two-Dose Hepatitis B Vaccine for Adults (Heplisav-B)
January 29, 2018 (Issue: 1539)
The FDA has approved a two-dose hepatitis B virus (HBV) vaccine (Heplisav-B – Dynavax) for use in adults ≥18 years old. The three other HBV vaccines marketed in the US are usually administered in 3 doses. Engerix-B and Recombivax HB are...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this issue?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this issue:
Title: Issue 1539
 


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.